Table 1.
Summary of the descriptive statistics for donor (d) and the recipient (r) that form the study donor after cardiac death cohort from which the donor after cardiac death risk index score was developed
| DCD donor and recipient variables | All (n = 261) | ||
| Donor | dAge (yr) | 46.1 ± 17.9 | |
| dBMI | 26 ± 4.9 | ||
| ITU Stay (d) | 3.9 ± 5.8 | ||
| COD (CVA: Other: HBI: Trauma) | 52.5:13.8:16.9:16.9 | ||
| dSodium (mmol/L) | 144.51 ± 11.8 | ||
| dBilirubin (μmol/L) | 9.81 ± 6.88 | ||
| Split/reduced (%) | 2.30% | ||
| WIT (min) | 16.7 ± 9.8 | ||
| dHepT (min) | 24.3 ± 10.6 | ||
| Liver Weight (g) | 1518.28 ± 397.507 | ||
| CIT (min) | 431 ± 118 | ||
| Recipient | rAge (yr) | 49.45 ± 15.36 | |
| rGender | 70.1%M/39.9%F | ||
| rBMI | 25.9 ± 4.7 | ||
| ALF (%) | 1.50% | ||
| rBilirubin (mmol/L) | 89.36 ± 116.38 | ||
| rINR | 1.89 ± 1.88 | ||
| MELD | 14.8 ± 6.4 | ||
| Location (inpatient/home) | 20.3%/79.6% | ||
| Prior abdominal surgery (yr) | 13.40% | ||
| reTPL (yr) | 5.70% | ||
| Indication for TPL | Low | 68 (26%) | |
| Standard | 176 (67.5%) | ||
| High | 17 (6.5%) | ||
Data presented as mean ± SD or % where appropriate. Primary indication for transplant has been divided into three risk groups of low, standard and high risk, as defined by their survival curves. BMI: Body mass index; COD: Cause of death; CVA: Cerebrovascular accident; HBI: Hypoxic brain injury; WIT: Warm ischemic time; CIT: Cold ischemic time; dHepT: Donor hepatectomy time; ALF: Acute liver failure; MELD: Model for end stage liver disease; reTPL: Retransplantation; TPL: Transplant.